Trial registration
ClinicalTrials.gov NCT02839720. Keywords: Cell-to-cell-communication; CellChat; Cutaneous neurofibroma; Differential gene expression; Ingenuity pathway analysis; Neurofibromatosis; RNA velocity; Scriabin; Selumetinib; Single nuclei sequencing; Tumor microenvironment.
